Voxeleron LLC was co-founded in 2010 by Daniel Russakoff and Jonathan Oakley to develop state-of-the-art software in the field of computer vision and machine learning. Our specialty is in the development of ophthalmic image analysis software for optical coherence tomography (OCT) imagery. In this area, our personnel have more experience developing and releasing analysis algorithms than any other institution, commercial or academic. Contact us to learn about our products or how Voxeleron LLC could, in a consultancy role, contribute to your organization.
Jonathan Oakley has a B.Sc. in Computer Science from the University of York, England, a Masters from University College, London, and a Ph.D. in medical image processing from the Swiss Federal Institute of Technology. Since then, he has spent more than a decade working on image processing algorithm development for KLA-Tencor, Fujifilm and Carl Zeiss Meditec Inc. His research interests are primarily in medical image processing, with a clear emphasis on ophthalmic applications.
Daniel Russakoff received an A.B. in Geophysics from Harvard University and his Ph.D. in Computer Science from Stanford. His research interests are in computer vision and pattern recognition in general, and biomedical image analysis in particular. He has authored numerous conference and journal papers and holds several patents on topics ranging from stereo vision to medical image registration. He has worked as a Computer Scientist at the National Institute of Standards and Technology and as Chief Scientist at Fujifilm’s San Jose Research Lab. His more recent work has been using probabilistic shape analysis and machine learning for segmentation of deformable structures in 2D and 3D radiological images.
Scientific Advisory Board
In addition to delivering state of the art custom software and solutions, Voxeleron is committed to its own program of research and development. Towards that end, Voxeleron’s Scientific Advisory Board was created to offer expertise and help guide the research to address the most interesting and relevant problems. Dr. Peter Calabresi serves as the Director of the Multiple Sclerosis Center, focusing on the diagnosis and management of Multiple Sclerosis (MS). He is the principal investigator on several clinical trials and oversees research projects seeking to create new anti-inflammatory and neuroprotective therapies for MS. Professor Calabresi has pioneered the use of optical coherence tomography (OCT) in MS identifying the relevance of retinal layers for both the screening and monitoring of this neurological disorder.